GlassScriptPhysician profile
Shannon Michelle Woods
NPI 1730697517
$1,979.54
in general payments reported to CMS, 2019-2025
20 companies · $997 in 2025
The $997 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $982 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,979.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $471.43 | 2024-2025 | |
| Amgen INC. | $326.30 | 2024-2025 | Repatha, Otezla, Repatha |
| Novo Nordisk INC | $217.91 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $163.13 | 2024-2025 | Caplyta |
| Lilly USA, LLC | $149.53 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $149.36 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.47 | 2024 | Jardiance |
| Glaxosmithkline, LLC. | $79.34 | 2024-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $44.66 | 2025 | Airsupra, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $41.24 | 2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $36.35 | 2025 | |
| Boston Scientific Corporation | $33.31 | 2024 | Bodyguardian |
| Axsome Therapeutics, INC. | $32.75 | 2025 | Auvelity |
| Exact Sciences Corporation | $29.40 | 2024-2025 | Cologuard Collection Kit |
| Averitas Pharma INC. | $25.78 | 2025 | Qutenza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.62 | 2025 | |
| Hologic Sales and Service, LLC | $21.40 | 2025 | Aptima |
| Otsuka America Pharmaceutical, INC. | $21.29 | 2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $17.50 | 2025 | Fanapt |
| Inspire Medical Systems, INC. | $15.77 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.